Acute angiotensin II receptor blockade improves insulin-induced microvascular function in hypertensive individuals

Microvascular Research

Volumn 82, Issue 1, 2011, Pages 77-83

  Jonk, Amy M ^a   Houben, Alfons J ^a   Schaper, Nicolaas C ^a   de Leeuw, Peter W ^a   Serné, Erik H ^b   Smulders, Yvo M ^b   Stehouwer, Coen D ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FELODIPINE; IRBESARTAN; NEUTRAL INSULIN; PLACEBO;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CAPILLARY DENSITY; CAPILLARY FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HUMAN; HYPEREMIA; HYPERINSULINEMIA; HYPERTENSION; INSULIN SENSITIVITY; MALE; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ANGIOTENSIN RECEPTOR ANTAGONISTS; BIPHENYL COMPOUNDS; BLOOD GLUCOSE; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DOUBLE-BLIND METHOD; FELODIPINE; FEMALE; GLUCOSE CLAMP TECHNIQUE; HEART RATE; HUMANS; HYPEREMIA; HYPERINSULINISM; HYPERTENSION; INSULIN; INSULIN RESISTANCE; MALE; MICROCIRCULATION; MICROVESSELS; MIDDLE AGED; NAILS; SKIN TEMPERATURE; TETRAZOLES;

EID: 79957800738     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2011.04.002     Document Type: Article

References (41)

1. Aksnes T.A., Reims H.M., Guptha S., et al. Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors. J. Hum. Hypertens. 2006, 20:860-866.
2. Aksnes T.A., Flaa A., Sevre K., et al. Effects on plasma noradrenaline may explain some of the improved insulin sensitivity seen by AT-1 receptor blockade. Blood Press. 2008, 17:156-163.
3. Andraws R., Brown D.L. Effect of inhibition of the renin-angiotensin system on development of type 2 diabetes mellitus (meta-analysis of randomized trials). Am. J. Cardiol. 2007, 99:1006-1012.
4. Andreozzi F., Laratta E., Sciacqua A., et al. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells. Circ. Res. 2004, 94:1211-1218.
5. Anon. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 26(Suppl 1):S5-S20.
6. Baron A.D., Tarshoby M., Hook G., et al. Interaction between insulin sensitivity and muscle perfusion on glucose uptake in human skeletal muscle: evidence for capillary recruitment. Diabetes 2000, 49:768-774.
7. Barrett E.J., Eggleston E.M., Inyard A.C., et al. The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action. Diabetologia 2009, 52:752-764.
8. Benndorf R.A., Rudolph T., Appel D., et al. Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension. Metabolism 2006, 55:1159-1164.
9. Chai W., Wang W., Liu J., et al. Angiotensin II type 1 and type 2 receptors regulate basal skeletal muscle microvascular volume and glucose use. Hypertension 2010, 55:523-530.
10. Clark M.G. Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E732-E750.
11. Coggins M., Lindner J., Rattigan S., et al. Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment. Diabetes 2001, 50:2682-2690.
12. de Jongh R.T., Serne E.H., Ijzerman R.G., et al. Free fatty acid levels modulate microvascular function: relevance for obesity-associated insulin resistance, hypertension, and microangiopathy. Diabetes 2004, 53:2873-2882.
13. DeFronzo R.A., Tobin J.D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 1979, 237:E214-E223.
14. Elliott W.J., Meyer P.M. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 2007, 369:201-207.
15. Eringa E.C., Stehouwer C.D., Merlijn T., et al. Physiological concentrations of insulin induce endothelin-mediated vasoconstriction during inhibition of NOS or PI3-kinase in skeletal muscle arterioles. Cardiovasc. Res. 2002, 56:464-471.
16. Ferrannini E., Mari A. How to measure insulin sensitivity. J. Hypertens. 1998, 16:895-906.
17. Fogari R., Preti P., Zoppi A., et al. Effect of valsartan addition to amlodipine on insulin sensitivity in overweight-obese hypertensive patients. Intern. Med. 2008, 47:1851-1857.
18. Fogari R., Zoppi A., Ferrari I., et al. Comparative effects of telmisartan and eprosartan on insulin sensitivity in the treatment of overweight hypertensive patients. Horm. Metab. Res. 2009, 41:893-898.
19. Furuhashi M., Ura N., Higashiura K., et al. Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 2003, 42:76-81.
20. Henriksen E.J., Jacob S., Kinnick T.R., et al. Selective angiotensin II receptor receptor antagonism reduces insulin resistance in obese Zucker rats. Hypertension 2001, 38:884-890.
21. Holowatz L.A., Thompson-Torgerson C.S., Kenney W.L. The human cutaneous circulation as a model of generalized microvascular function. J. Appl. Physiol. 2008, 105:370-372.
22. Jonk A.M., Houben A.J., Schaper N.C., et al. Angiotensin II enhances insulin-stimulated whole-body glucose disposal but impairs insulin-induced capillary recruitment in healthy volunteers. J. Clin. Endocrinol. Metab. 2010, 95:3901-3908.
23. Kim F., Pham M., Maloney E., et al. Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1982-1988.
24. Krusinova E., Klementova M., Kopecky J., et al. Effect of acute hyperinsulinaemia with and without angiotensin II type 1 receptor blockade on resistin and adiponectin concentrations and expressions in healthy subjects. Eur. J. Endocrinol. 2007, 157:443-449.
25. Lang C.H. Rates and tissue sites of noninsulin- and insulin-mediated glucose uptake in diabetic rats. Proc. Soc. Exp. Biol. Med. 1992, 199:81-87.
26. Lee M.H., Song H.K., Ko G.J., et al. Angiotensin receptor blockers improve insulin resistance in type 2 diabetic rats by modulating adipose tissue. Kidney Int. 2008, 74:890-900.
27. Li R., Zhang H., Wang W., et al. Vascular insulin resistance in prehypertensive rats: role of PI3-kinase/Akt/eNOS signaling. Eur. J. Pharmacol. 2010, 628:140-147.
28. Newman J.M., Dwyer R.M., St-Pierre P., et al. Decreased microvascular vasomotion and myogenic response in rat skeletal muscle in association with acute insulin resistance. J. Physiol. 2009, 587:2579-2588.
29. Paolisso G., Tagliamonte M.R., Gambardella A., et al. Losartan mediated improvement in insulin action is mainly due to an increase in non-oxidative glucose metabolism and blood flow in insulin-resistant hypertensive patients. J. Hum. Hypertens. 1997, 11:307-312.
30. Potenza M.A., Marasciulo F.L., Chieppa D.M., et al. Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H813-H822.
31. Ribstein J., Picard A., Armagnac C., et al. Inhibition of the acute effects of angiotensin II by the receptor antagonist irbesartan in normotensive men. J. Cardiovasc. Pharmacol. 2001, 37:449-460.
32. Rizzoni D., Pasini E., Flati V., et al. Angiotensin receptor blockers improve insulin signaling and prevent microvascular rarefaction in the skeletal muscle of spontaneously hypertensive rats. J. Hypertens. 2008, 26:1595-1601.
33. Salmasi A.M., Belcaro G., Nicolaides A.N. Impaired venoarteriolar reflex as a possible cause for nifedipine-induced ankle oedema. Int. J. Cardiol. 1991, 30:303-307.
34. Serne E.H., Gans R.O., ter Maaten J.C., et al. Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension 2001, 38:238-242.
35. Serne E.H., Gans R.O., ter Maaten J.C., et al. Capillary recruitment is impaired in essential hypertension and relates to insulin's metabolic and vascular actions. Cardiovasc. Res. 2001, 49:161-168.
36. Serne E.H., Ijzerman R.G., Gans R.O., et al. Direct evidence for insulin-induced capillary recruitment in skin of healthy subjects during physiological hyperinsulinemia. Diabetes 2002, 51:1515-1522.
37. Velloso L.A., Folli F., Sun X.J., et al. Cross-talk between the insulin and angiotensin signaling systems. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:12490-12495.
38. Vincent M.A., Barrett E.J., Lindner J.R., et al. Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. Am. J. Physiol. Endocrinol. Metab. 2003, 285:E123-E129.
39. Wei Y., Whaley-Connell A.T., Chen K., et al. NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat. Hypertension 2007, 50:384-391.
40. Zhang L., Vincent M.A., Richards S.M., et al. Insulin sensitivity of muscle capillary recruitment in vivo. Diabetes 2004, 53:447-453.
41. Zhou M.S., Schulman I.H., Raij L. Role of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertension. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H833-H839.